Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Nature Medicine|December 1, 1995
In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latencyT W Chun, D Finzi, J Margolick, et al.Current Topics in Microbiology and Immunology|January 1, 1996
The role of CD4 in HIV envelope-mediated pathogenesisR F SilicianoThe Journal of Infectious Diseases|November 24, 1999
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoirF Lori, H Jessen, J Lieberman, et al.The Journal of Infectious Diseases|November 9, 2000
Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infectionJ N Blankson, D Finzi, T C Pierson, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 1999
Cutting edge: induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigenT Tobery, R F SilicianoScience (New York, N.Y.)|February 24, 2001
Preventing AIDS but not HIV-1 infection with a DNA vaccineX Shen, R F SilicianoThe Journal of Clinical Investigation|April 5, 2000
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected childrenD Persaud, T Pierson, C Ruff, et al.The Journal of Experimental Medicine|March 3, 1997
Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunizationT W Tobery, R F SilicianoJournal of Virology|August 10, 2000
Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1T Pierson, T L Hoffman, J Blankson, et al.Current Opinion in Infectious Diseases|October 13, 2006
Latent reservoirs for HIV-1J Blankson, D Persaud, R F SilicianoPageof 7